The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010
Open accessAbstract
Background: Increasing rates of prescriptions for antidepressants, antipsychotics and stimulants have been reported from various countries. Aims: To examine trends in prescriptions and the costs of all classes of psychiatric medication in England. Method: Data from the Prescription Cost Analysis 1998–2010 was examined, using linear regression analysis to examine trends. Results: Prescriptions of drugs used for mental disorders increased by 6.8% (95% CI 6.3–7.4) per year on average, in line with other drugs, but made up an increasing proportion of all prescription drug costs (P = 0.001). There were rising trends in prescriptions of all classes of psychiatric drugs, except anxiolytics and hypnotics (which did not change). Antidepressant prescriptions increased by 10% (95% CI 9.0–11) per year on average, and antipsychotics by 5.1% (95% CI 4.3–5.9). Antipsychotics overtook antidepressants as the most costly class of psychiatric medication, with costs rising 22% (95% CI 17–27) per year. Conclusions: Rising prescriptions may be partly explained by longer-term treatment and increasing population. Nevertheless, it appears that psychiatric drugs make an increasing contribution to total prescription drug costs, with antipsychotics becoming the most costly. Low-dose prescribing of some antipsychotics is consistent with other evidence that their use may not be restricted to those with severe mental illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
The Rising Prevalence of Chronic Low Back Pain
Freburger, J. K., Holmes, G. M., Agans, R. P., Jackman, A. M., Darter, J. D., Wallace, A. S., Castel, L. D., Kalsbeek, W. D., & Carey, T. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.543 · Cited by 1,507 · cited 1×
“28 There are no recommended levels of prescriptions for anti-depressants or other psychiatric medications, and the increasing prescriptions for antidepressants may reflect increasing awareness of depression and other mental disorders among the general public and prescribers that most would welcome.”
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1032 · Cited by 724
Osborn, D. P. J., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.242 · Cited by 608
Increasing off‐label use of antipsychotic medications in the United States, 1995–2008
Alexander, G. C., Gallagher, S. A., Mascola, A., Moloney, R. M., & Stafford, R. S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2082 · Cited by 423
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
Antipsychotic prescribing trends: a review of pharmaco‐epidemiological studies
Verdoux, H., Tournier, M., & Bégaud, B. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01425.x · Cited by 249
Trends in Medication Treatment for ADHD
Castle, L., Aubert, R. E., Verbrugge, R. R., Khalid, M., & Epstein, R. S. (2007) · Journal of Attention Disorders · doi:10.1177/1087054707299597 · Cited by 242
Cited by
Jorm, A. F., Patten, S. B., Brugha, T. S., & Mojtabai, R. (2017) · World Psychiatry · doi:10.1002/wps.20388 · Cited by 556
Influences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Sheehan, R., Hassiotis, A., Walters, K., Osborn, D., Strydom, A., & Horsfall, L. (2015) · BMJ · doi:10.1136/bmj.h4326 · Cited by 403
Current Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217
“The prescription of psychotropics in the UK increased by 6.8% each year between 1998 and 2010, with antidepressant prescriptions alone increasing by 10% per year (Ilyas and Moncrieff, 2012).”
BackgroundResultInfluentialPsychotropic medicine consumption in 65 countries and regions, 2008-19: A longitudinal study
Brauer, R., Alfageh, B., Blais, J. E., Chan, E. W., Chui, C. S. L., Hayes, J. F., Man, K. K. C., Lau, W. C. Y., Yan, V. K. C., Beykloo, M. Y., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00292-3 · Cited by 203
Read, J., & Williams, J. (2018) · Current Drug Safety · doi:10.2174/1574886313666180605095130 · Cited by 175
Dowrick, C., & Frances, A. (2013) · BMJ · doi:10.1136/bmj.f7140 · Cited by 167
Read, J., Cartwright, C., & Gibson, K. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.01.042 · Cited by 150
Behavioural activation therapy for depression in adults
Uphoff, E., Ekers, D., Robertson, L., Dawson, S., Sanger, E., South, E., Samaan, Z., Richards, D., Meader, N., & Churchill, R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013305.pub2 · Cited by 98
The reappraisal of benzodiazepines in the treatment of anxiety and related disorders
Starcevic, V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.963057 · Cited by 90
“Are second-generation antipsychotics an alternative to BDZs for anxiety disorders? In addition to showing that the number of prescriptions for BDZs has been steady or decreased slightly over the past 10–15 years, studies from England and Australia have reported an exponential increase in the utilization of the secondg…”
BackgroundResultInfluentialAmbresin, G., Palmer, V., Densley, K., Dowrick, C., Gilchrist, G., & Gunn, J. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.055 · Cited by 61
“In the UK, between 1998 and 2010, antidepressant prescribing increased, on average, by 10% per year at a cost of d220 million (Ilyas and Moncrieff, 2012).”
BackgroundHsu, W.-T., Esmaily-Fard, A., Lai, C.-C., Zala, D., Lee, S.-H., Chang, S.-S., & Lee, C.-C. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.020 · Cited by 59
Staying on, and coming off, antidepressants: The experiences of 752 UK adults
Read, J., Gee, A., Diggle, J., & Butler, H. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.021 · Cited by 48
Read, J., Cartwright, C., Gibson, K., Shiels, C., & Haslam, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.010 · Cited by 42
Beliefs of people taking antidepressants about the causes of their own depression
Read, J., Cartwright, C., Gibson, K., Shiels, C., & Magliano, L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.009 · Cited by 37
“Concerns about over-prescribing are often framed within a broader critique about the ‘medicalisation’ of distress (Dowrick and Frances, 2013; Ilyas and Moncrieff, 2012; Read and Dillon, 2013).”
BackgroundPrescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study
Cressman, A. M., Macdonald, E. M., Huang, A., Gomes, T., Paterson, M. J., Kurdyak, P. A., Mamdani, M. M., & Juurlink, D. N. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000406 · Cited by 37
How many of 1829 antidepressant users report withdrawal effects or addiction?
Read, J., Cartwright, C., & Gibson, K. (2018) · International Journal of Mental Health Nursing · doi:10.1111/inm.12488 · Cited by 36
Bowers, H. M., Williams, S. J., Geraghty, A. W. A., Maund, E., O’brien, W., Leydon, G., May, C. R., & Kendrick, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027837 · Cited by 31
Cheng, B.-H., Chen, P.-C., Yang, Y.-H., Lee, C.-P., Huang, K.-E., & Chen, V. C. (2016) · Medicine · doi:10.1097/md.0000000000004655 · Cited by 31
Jayasooriya, N., Blackwell, J., Saxena, S., Bottle, A., Petersen, I., Creese, H., Hotopf, M., Pollok, R. C. G., & POP‐IBD study group (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16820 · Cited by 27
“18,19 We excluded tricyclic antidepressants from our main analysis since we previously found they are primarily prescribed at low dose for indications other than anxiety and depression.”
Understanding the non‐pharmacological correlates of self‐reported efficacy of antidepressants
Read, J., Gibson, K., Cartwright, C., Shiels, C., Dowrick, C., & Gabbay, M. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12390 · Cited by 20
“In England, prescriptions for ADs increased 10% per year between 1998 and 2010 (2).”
BackgroundLong-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C. (2019) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180046 · Cited by 14
Boland, M., Higgins, A., Beecher, C., Bracken, P., Burn, W., Cody, A., Framer, A., Gronlund, T., Horowitz, M., Huff, C., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-088266 · Cited by 14
False Beliefs in Academic Psychiatry: The Case of Antidepressant Drugs
Hengartner, M. P., & Plöderl, M. (2018) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.20.1.6 · Cited by 10
Do GPs and psychiatrists recommend alternatives when prescribing anti-depressants?
Read, J., Gibson, K., & Cartwright, C. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.069 · Cited by 7
Opium and the People: The Prescription Psychopharmaceutical Epidemic in Historical Context
Moncrieff, J. (2017) · The Sedated Society · doi:10.1007/978-3-319-44911-1_4 · Cited by 2
Self-citation
Metadata
- Authors
- Ilyas, S., & Moncrieff, J.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2012-05
- Volume
- 200
- Issue
- 5
- Pages
- 393-398
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2147717090
- Cited by
- 260
- References
- 20
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.